HoyleCohen, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
HoyleCohen, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$399,088
+7.1%
3,918
+6.1%
0.04%
+12.1%
Q2 2023$372,661
+9.7%
3,6930.0%0.03%
+3.1%
Q1 2023$339,756
-20.2%
3,693
-21.3%
0.03%
-23.8%
Q4 2022$425,749
+8.6%
4,693
-9.1%
0.04%
-2.3%
Q3 2022$392,000
-11.9%
5,160
-1.9%
0.04%
-6.5%
Q2 2022$445,000
-5.3%
5,259
-1.8%
0.05%
+15.0%
Q1 2022$470,000
-3.5%
5,353
-3.9%
0.04%0.0%
Q4 2021$487,000
+20.8%
5,573
+13.2%
0.04%
+5.3%
Q3 2021$403,000
-10.2%
4,9220.0%0.04%
+8.6%
Q2 2021$449,000
+6.4%
4,922
-0.3%
0.04%
-18.6%
Q1 2021$422,000
-12.8%
4,937
-3.6%
0.04%
-23.2%
Q4 2020$484,000
+5.7%
5,122
-2.8%
0.06%
-16.4%
Q3 2020$458,000
+3.4%
5,272
+3.9%
0.07%
-9.5%
Q2 2020$443,000
+6.0%
5,0720.0%0.07%
-10.8%
Q1 2020$418,000
-13.6%
5,072
-0.8%
0.08%
+7.8%
Q4 2019$484,000
+9.0%
5,1120.0%0.08%
+1.3%
Q3 2019$444,000
-4.9%
5,1120.0%0.08%
-6.2%
Q2 2019$467,000
+62.7%
5,112
+71.1%
0.08%
+58.8%
Q1 2019$287,000
+41.4%
2,987
+26.0%
0.05%
+24.4%
Q4 2018$203,000
-0.5%
2,3710.0%0.04%
+7.9%
Q3 2018$204,000
-15.0%
2,371
-20.2%
0.04%
-22.4%
Q1 2018$240,000
-10.1%
2,971
-6.7%
0.05%
-7.5%
Q4 2017$267,0003,1840.05%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
MANAGED ASSET PORTFOLIOS, LLC 332,962$27,452,0007.32%
Mawer Investment Management Ltd. 7,721,327$636,623,0005.86%
Martin Investment Management, LLC 133,246$10,986,0005.56%
SCHARF INVESTMENTS, LLC 1,330,175$109,673,0005.48%
Hansberger Growth Investors, LP 46,663$3,847,0005.19%
Bain Capital Public Equity Management II, LLC 440,233$36,297,0004.25%
First Fiduciary Investment Counsel, Inc. 187,633$15,470,0004.10%
GARLAND CAPITAL MANAGEMENT INC 53,555$4,416,0004.02%
Lowell Blake & Associates Inc. 37,219$3,069,0003.94%
PRENTISS SMITH & CO INC 68,027$5,609,0003.89%
View complete list of NOVARTIS A G shareholders